Login to Your Account



A 'Fillip' For UK Biotech

Roche Buying Privately Held Piramed for $160M Up Front

By Jennifer Boggs


Wednesday, April 16, 2008
Less than five years after its founding, privately held Piramed Ltd. agreed to be acquired by Roche Holdings Ltd. for $160 million up front in one of the few recent deals to stand out in the slumping UK biotech sector. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription